Rentz, A; Flood, E; Altisent, C et al.
Cross-cultural development and psychometric evaluation of a patient-reported health-related quality of life questionnaire for adults with haemophiliaHaemophilia. Bd. 14. 2008 S. 1023-34
Sebastian, M; Fischer, B; Buhl, R
Das Lungenkarzinom des NichtrauchersJournal Onkologie. Bd. 7. 2008 S. 349-52
Hartwig, UF; Nonn, M; Khan, S et al.
Depletion of alloreactive donor T lymphocytes by CD95-mediated activation-induced cell death retains antileukemic, antiviral, and immunoregulatory T cell immunity.Biol Blood Marrow Transplant. Bd. 14. H. 1. 2008 S. 99-109
Wolfel, C; Lennerz, V; Lindemann, E et al.
Dissection and molecular analysis of alloreactive CD8+ T cell responses in allogeneic haematopoietic stem cell transplantation.Cancer Immunol Immunother. Bd. 57. H. 6. 2008 S. 849-57
Zindler, E; Gehrke, N; Luft, C et al.
Divergent effects of biolistic gene transfer in a mouse model of allergic airway inflammation.Am J Respir Cell Mol Biol. Bd. 38. H. 1. 2008 S. 38-46
Kaskel, P; Tuschy, S; Wagner, A et al.
Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital setting.Ann Hematol. Bd. 87. H. 4. 2008 S. 311-9
Gronke, L; Beeh, KM; Cameron, R et al.
Effect of the oral leukotriene B(4) receptor antagonist LTB019 on inflammatory sputum markers in patients with chronic obstructive pulmonary disease.Pulm Pharmacol Ther. Bd. 21. H. 2. 2008 S. 409-417
Lipka, D; Heidel, F; Huber, C et al.
Entwicklung von Tyrosinkinase-Inhibitoren bei hamatologischen Neoplasien. FLT3 und JAK2 als therapeutische Targets.Pharm Unserer Zeit. Bd. 37. H. 5. 2008 S. 394-403
Cook, L; Miyahara, N; Jin, N et al.
Evidence that CD8+ dendritic cells enable the development of gammadelta T cells that modulate airway hyperresponsiveness.J Immunol. Bd. 181. H. 1. 2008 S. 309-19
Hochhaus, A; Druker, B; Sawyers, C et al.
Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatment.Blood. Bd. 111. H. 3. 2008 S. 1039-43